TY - JOUR
T1 - Contamination of nebulizer equipment with cockroach allergen
T2 - There's a bug in the system!
AU - Bollinger, Mary E.
AU - Wolf, Brian
AU - Schwindt, Christina
AU - Hamilton, Robert G.
PY - 2004/4
Y1 - 2004/4
N2 - Background: Physicians often have anecdotal reports of patients describing increased asthma symptoms after the use of nebulizers; however, there are few published reports of nebulizer-associated exacerbations. Objective: To present 2 cases of asthmatic children who experienced a life-threatening exacerbation of their symptoms after nebulizer use. Methods: Case 2's nebulizer was tested for cockroach allergen by washing the medication reservoir with 2 mL of sterile filtered 1% phosphate-buffered saline, 0.05% bovine serum albumin, and Tween 20 overnight with rotation. The patient's sealed albuterol nebulizer medication was used as a control. The control albuterol and test solutions were analyzed for Blattella germanica 1 and 2 allergens using a monoclonal antibody-based immunoenzymetric assay. Results: The reservoir from case 2 was found to have measurable levels of both Bla g 1 and Bla g 2. The control albuterol solution had no measurable cockroach allergen. An insect found in the nebulizer box of case 2 was identified as an infantile German cockroach. Conclusions: Nebulizer use provides an opportunity for antigen exposure directly to small airways, which may lead to severe allergic reactions in patients using contaminated equipment.
AB - Background: Physicians often have anecdotal reports of patients describing increased asthma symptoms after the use of nebulizers; however, there are few published reports of nebulizer-associated exacerbations. Objective: To present 2 cases of asthmatic children who experienced a life-threatening exacerbation of their symptoms after nebulizer use. Methods: Case 2's nebulizer was tested for cockroach allergen by washing the medication reservoir with 2 mL of sterile filtered 1% phosphate-buffered saline, 0.05% bovine serum albumin, and Tween 20 overnight with rotation. The patient's sealed albuterol nebulizer medication was used as a control. The control albuterol and test solutions were analyzed for Blattella germanica 1 and 2 allergens using a monoclonal antibody-based immunoenzymetric assay. Results: The reservoir from case 2 was found to have measurable levels of both Bla g 1 and Bla g 2. The control albuterol solution had no measurable cockroach allergen. An insect found in the nebulizer box of case 2 was identified as an infantile German cockroach. Conclusions: Nebulizer use provides an opportunity for antigen exposure directly to small airways, which may lead to severe allergic reactions in patients using contaminated equipment.
UR - http://www.scopus.com/inward/record.url?scp=3042722357&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3042722357&partnerID=8YFLogxK
U2 - 10.1016/S1081-1206(10)61786-3
DO - 10.1016/S1081-1206(10)61786-3
M3 - Article
C2 - 15104202
AN - SCOPUS:3042722357
SN - 1081-1206
VL - 92
SP - 475
EP - 477
JO - Annals of Allergy, Asthma and Immunology
JF - Annals of Allergy, Asthma and Immunology
IS - 4
ER -